In FDA v. Alliance for Hippocratic Medicine, the high court will hear from anti-abortion advocates who argue that mifepristone, which wasin combination with misoprostol in 63% of abortions in the U.S. last year, is too easy to access. If the Supreme Court agrees, medicated abortions could become much harder to obtain. The case also has important implications for miscarriage care, as the drug is frequently used to manage pregnancy loss without additional medical procedures.
Judge Matthew Kacsmaryk, who initially ruled on the case, cited the studies last year in an April 2023 opinion suspending the FDA’s 2000 approval of mifepristone. The studies were subsequently retracted by the academic publisher Sage, along with one other study by the same researchers.
In November, abortion rights advocates in the state hope to make gains in the legislature and, no less important, to defeat GOP gubernatorial nominee Mark Robinson, an outspoken right-wing politician who has called abortion a “scourge” and said he wants to push the limit on abortion to six weeks.Speaking on MSNBC’s “Morning Joe,” New York Gov.
Good morning from outside the Supreme Court, where Whitney Houston's"I'm Every Woman" is blasting, the ACLU is handing out fig bars and hundreds of people are here rallying in support of abortion rights as the court hears a flimsy abortion pill challenge. Self-managed abortions using abortion pills increased in the six months following the Supreme Court decision that repealed federal abortion protections, new research shows.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: HuffPostCanada - 🏆 61. / 53 Read more »